Mettler-Toledo International (NYSE:MTD) Upgraded at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Mettler-Toledo International (NYSE:MTD) from a hold rating to a buy rating in a research note issued to investors on Friday, MarketBeat reports. The brokerage currently has $1,450.00 price target on the medical instruments supplier’s stock, up from their previous price target of $1,400.00.

A number of other brokerages have also recently commented on MTD. The Goldman Sachs Group initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 target price for the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research note on Monday, December 15th. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective for the company in a research note on Monday, December 15th. Finally, Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $1,463.75.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD opened at $1,205.77 on Friday. The stock’s 50-day simple moving average is $1,351.42 and its two-hundred day simple moving average is $1,366.03. The stock has a market capitalization of $24.42 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 2.53 and a beta of 1.43. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $12.41 EPS. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, equities analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.77% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. boosted its position in shares of Mettler-Toledo International by 83.3% during the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after acquiring an additional 30 shares during the last quarter. Creative Planning lifted its stake in Mettler-Toledo International by 24.5% in the 2nd quarter. Creative Planning now owns 3,574 shares of the medical instruments supplier’s stock worth $4,198,000 after purchasing an additional 703 shares in the last quarter. Cetera Investment Advisers lifted its stake in Mettler-Toledo International by 8.4% in the 2nd quarter. Cetera Investment Advisers now owns 1,335 shares of the medical instruments supplier’s stock worth $1,568,000 after purchasing an additional 104 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Mettler-Toledo International by 0.5% during the 2nd quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier’s stock valued at $3,003,415,000 after purchasing an additional 13,342 shares during the last quarter. Finally, TD Waterhouse Canada Inc. grew its position in shares of Mettler-Toledo International by 53.9% during the second quarter. TD Waterhouse Canada Inc. now owns 234 shares of the medical instruments supplier’s stock valued at $282,000 after purchasing an additional 82 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.